← All diseases Cancer

Melanoma (metastatic)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the strongest evidence (27)Meta-analysis (4)Treatment guideline (2)Systematic review (8)Phase 3 study (7)Randomized trial (6)Clinical trial (585)Review article (181)Early study (phase 1 or 2) (54)Case report (241)Laboratory or animal study (45)Commentary or editorial (17)Retracted publication (2) Studies currently recruiting participants only (39)

Filter

Publications and studies (1860)

• The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma. (2019/01/04) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Indications for the surgical resection of stage IV disease. (2019/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. An open-label, multicentre safety study of vemurafenib in patients with BRAF(V600)-mutant metastatic melanoma: final analysis and a validated prognostic scoring system. (2019/01/01) ♡
• 5-(3,3-Dimethyle-1-Triazeno) Imidazole-4-Carboxamide and Interleukin-2 Adjuvant Therapy in Resected High-Risk Primary and Regionally Metastatic Melanoma. (2019/01/01) ♡
• Overexpression of TBX3 transcription factor as a potential diagnostic marker for breast cancer. (2019/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advanced stage melanoma therapies: Detailing the present and exploring the future. (2019/01/01) ♡
• Hemorrhagic occlusive retinal vasculitis leading to the diagnosis of ciliary body melanoma. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Diet-dependent toxicity of ipilimumab in metastatic melanoma. (2019/01/01) ♡
• Clinical Studies of Methionine-Restricted Diets for Cancer Patients. (2019/01/01) ♡
• Secondary glaucoma in small versus large uveal melanoma patients treated with stereotactic radiosurgery on linear accelerator. (2019/01/01) ♡
• The Targeted Therapies Era Beyond the Surgical Point of View: What Spine Surgeons Should Know Before Approaching Spinal Metastases. (2019/01/01) ♡
• Touch Imprinting Cytology may be useful in the intraoperative evaluation of the sentinel lymph node in melanoma. (2019/01/01) ♡
• Melanoma liver metastases with special imaging features on magnetic resonance imaging after microwave ablations: How to evaluate technical efficacy? (2019/01/01) ♡
• The Clinical Significance of Incidental Parotid Uptake in a PET/CT Study: A Diagnostic Algorithm. (2019/01/01) ♡
• Cancer immunotherapy experience in the Integral Oncology Centre "Diana Laura Riojas de Colosio", Médica Sur Hospital. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Long-Term Survival of Cutaneous Malignant Melanoma with Metastasis to Paranasal Sinuses: A Case Report and Literature Review. (2018/12/31) ♡
• TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness. (2018/12/28) ♡
• Surgery of primary tumor improves the survival of newly diagnosed metastatic melanoma: a population-based, propensity-matched study. (2018/12/27) ♡
• Lymph Node Ratio: Is It an Independent Prognostic Factor for Stage III Cutaneous Melanoma? (2018/12/25) ♡
• Prevalence of pathogenic/likely pathogenic variants in the 24 cancer genes of the ACMG Secondary Findings v2.0 list in a large cancer cohort and ethnicity-matched controls. (2018/12/24) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Radiolabelled Aptamers for Theranostic Treatment of Cancer. (2018/12/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Infliximab for treatment-refractory transverse myelitis following immune therapy and radiation. (2018/12/22) ♡
• Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma. (2018/12/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Thrombotic Thrombocytopenic Purpura due to Checkpoint Inhibitors. (2018/12/20) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Evaluation of planar bioluminescence imaging and microPET/CT for therapy monitoring in a mouse model of pigmented metastatic melanoma. (2018/12/20) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma. (2018/12/19) ♡
• Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients. (2018/12/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System. (2018/12/19) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Comparative Analysis of the "Scholastic" Recommendations of the AJCC From 2011 for the Surgical Treatment of Cutaneous Melanoma with the Newly Suggested Guidelines for OSMS From the Bulgarian Society For Dermatologic Surgery! (2018/12/18) ♡
• Phosphorylated Akt1 expression is associated with poor prognosis in cutaneous, oral and sinonasal melanomas. (2018/12/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. PD-1 inhibitor induced alopecia areata. (2018/12/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy. (2018/12/14) ♡
• Microenvironment-derived ADAM28 prevents cancer dissemination. (2018/12/14) ♡
• Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors. (2018/12/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors. (2018/12/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cytokines, Chemokines, and Other Biomarkers of Response for Checkpoint Inhibitor Therapy in Skin Cancer. (2018/12/12) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up. (2018/12/12) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. NEO412: A temozolomide analog with transdermal activity in melanoma in vitro and in vivo. (2018/12/11) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pathological complete response induced by neoadjuvant treatment using BRAF and MEK inhibitors in a patient with unresectable BRAF V600E-mutant malignant melanoma of the gallbladder. (2018/12/04) ♡
• Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma. (2018/12/02) ♡
• Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience. (2018/12/01) ♡
• Vol-PACT: A Foundation for the NIH Public-Private Partnership That Supports Sharing of Clinical Trial Data for the Development of Improved Imaging Biomarkers in Oncology. (2018/12/01) ♡
• Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma. (2018/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [A case of endometrium adenocarcinoma with multiple cavitary pulmonary metastasis]. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Practical clinical guide on the use of talimogene laherparepvec monotherapy in patients with unresectable melanoma in Europe. (2018/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The great escape: How metastases of melanoma, and other carcinomas, avoid elimination. (2018/12/01) ♡
• Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I : C) promote melanoma regression. (2018/11/29) ♡
• Batf3(+) DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy. (2018/11/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. BRAF V600E Mutation in Multiple Primary Malignancies: A Hairy Affair. (2018/11/16) ♡
• On the spectral signature of melanoma: a non-parametric classification framework for cancer detection in hyperspectral imaging of melanocytic lesions. (2018/11/15) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.